UPDATE 1-Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 mln
December 26, 2019 at 23:40 PM EST
* Deal consists of $120 mln upfront, rest in milestone payments
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|